Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England.

Gema Requena,Alexandrosz Czira,Victoria Banks,Robert Wood,Theo Tritton,Catherine M Castillo, Jie Yeap,Rosie Wild,Chris Compton,Kieran J Rothnie,Felix Herth,Jennifer K Quint,Afisi S Ismaila

International journal of chronic obstructive pulmonary disease（2023）

引用 0|浏览15

暂无评分

摘要

UMEC/VI was superior to TIO/OLO in reducing rescue medication prescriptions at 12 months after treatment initiation in a primary care cohort in England, potentially suggesting improvements in symptom control with UMEC/VI compared with TIO/OLO.

查看译文

关键词

rescue medication prescriptions,chronic obstructive pulmonary disease,tiotropium bromide/olodaterol

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要